HIV/AIDS Topics CROI 2012: Drug Levels Predict Efficacy in PrEP Trials, Highlighting Importance of Adherence
- Details
- Category: HIV Prevention
- Published on Thursday, 08 March 2012 00:00
- Written by Paul Dalton
Two analyses of PrEP studies presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle found that drug levels -- and by implication, adherence -- were strongly correlated with protection against HIV infection.
CROI 2012: Studies Advance Development of Microbicides for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Thursday, 08 March 2012 00:00
- Written by Paul Dalton
A pair of studies presented in an oral session at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) taking place this week in Seattle addressed the safety and acceptability of experimental microbicide preparations. Both studies found the microbicides to be well tolerated and acceptable.
CROI 2012: Hormonal Contraception May Raise HIV Risk for Women, but Uncertainty Remains
- Details
- Category: HIV Sexual Transmission
- Published on Wednesday, 07 March 2012 00:00
- Written by Keith Alcorn
Injectable hormonal contraception may raise the risk of HIV infection for women, but it does not appear to increase the risk of HIV disease progression in women with HIV, according to findings from 2 new studies presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle.
CROI 2012: Final Partners PrEP Results Confirm Efficacy of Oral Antiretrovirals for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Wednesday, 07 March 2012 00:00
- Written by Paul Dalton
Daily, oral pre-exposure prophylaxis (PrEP) using either tenofovir (Viread) or tenofovir/emtricitabine (Truvada) was highly effective at preventing HIV infection in a large study of serodiscordant heterosexual couples in sub-Saharan Africa, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle.
CROI 2012: Broadly Neutralizing Antibodies Can Help Fight HIV [VIDEO]
- Details
- Category: HIV Vaccines
- Published on Tuesday, 06 March 2012 00:00
- Written by Gregory Fowler
Recent discoveries about broadly neutralizing antibodies are helping advance the field of HIV vaccine development, according to Dennis Burton from the Scripps Research Institute and the Ragon Institute of MGH, MIT, and Harvard, who presented the annual Bernard Fields Lecture on Monday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.
More Articles...
- CROI 2012: Conference Overview Highlights Biomedical HIV Prevention
- Conference on Retroviruses and Opportunistic Infections Opens Next Week in Seattle
- WHO Affirms That Women at Risk for HIV Should Continue To Use Injectable Contraceptives
- Vacc-4x Therapeutic HIV Vaccine Linked to Lower Viral Load in Phase IIb Study
Web Design and Development by